Dechert advised AlgoTherapeutix on the deal. AlgoTherapeutix, a French biotech company which develops topical pain relief treatment for chemotherapy-induced peripheral neuropathy (CIPN), completed its €12 million…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
